Vertex Pharmaceuticals, Inc. (VRTX)
442.80
-4.03
(-0.90%)
USD |
NASDAQ |
Jun 08, 15:36
Vertex Pharmaceuticals EPS Diluted (Quarterly) : 4.024 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Biogen, Inc. | 2.153 |
| CRISPR Therapeutics AG | -1.280 |
| Halozyme Therapeutics, Inc. | 1.221 |
| Gilead Sciences, Inc. | 1.612 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.031B |
| Revenue (Quarterly) | 3.012B |
| Total Expenses (Quarterly) | 1.981B |
| Enterprise Value | 108.30B |
| Gross Profit Margin (Quarterly) | 86.96% |
| Profit Margin (Quarterly) | 34.24% |
| Earnings Yield | 3.81% |
| Operating Earnings Yield | 4.32% |
| Normalized Earnings Yield | 3.889 |